List of Tables
    Table 1. Angiotensin Receptor Antagonists CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Angiotensin Receptor Antagonists Market Trends
    Table 3. Angiotensin Receptor Antagonists Market Drivers
    Table 4. Angiotensin Receptor Antagonists Market Challenges
    Table 5. Angiotensin Receptor Antagonists Market Restraints
    Table 6. Global Angiotensin Receptor Antagonists Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Angiotensin Receptor Antagonists Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Angiotensin Receptor Antagonists Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Angiotensin Receptor Antagonists Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Angiotensin Receptor Antagonists Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Angiotensin Receptor Antagonists Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Angiotensin Receptor Antagonists Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Angiotensin Receptor Antagonists Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Angiotensin Receptor Antagonists Sales Share by Manufacturer, 2017-2022
    Table 15. Global Angiotensin Receptor Antagonists Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Angiotensin Receptor Antagonists Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Angiotensin Receptor Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiotensin Receptor Antagonists as of 2021)
    Table 18. Top Players of Angiotensin Receptor Antagonists in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Angiotensin Receptor Antagonists Product Type
    Table 20. Date of International Manufacturers Enter into Angiotensin Receptor Antagonists Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Angiotensin Receptor Antagonists Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Angiotensin Receptor Antagonists Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Angiotensin Receptor Antagonists Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Angiotensin Receptor Antagonists Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Angiotensin Receptor Antagonists Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Angiotensin Receptor Antagonists Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Angiotensin Receptor Antagonists Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Angiotensin Receptor Antagonists Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Angiotensin Receptor Antagonists Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Angiotensin Receptor Antagonists Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Angiotensin Receptor Antagonists Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Angiotensin Receptor Antagonists Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Angiotensin Receptor Antagonists Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Angiotensin Receptor Antagonists Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Angiotensin Receptor Antagonists Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Angiotensin Receptor Antagonists Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Angiotensin Receptor Antagonists Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Angiotensin Receptor Antagonists Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Angiotensin Receptor Antagonists Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Angiotensin Receptor Antagonists Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Pfizer Corporation Information
    Table 43. Pfizer Description and Business Overview
    Table 44. Pfizer Angiotensin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Pfizer Angiotensin Receptor Antagonists Product
    Table 46. Pfizer Recent Development
    Table 47. Novartis Corporation Information
    Table 48. Novartis Description and Business Overview
    Table 49. Novartis Angiotensin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Novartis Product
    Table 51. Novartis Recent Development
    Table 52. Merck Corporation Information
    Table 53. Merck Description and Business Overview
    Table 54. Merck Angiotensin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Merck Product
    Table 56. Merck Recent Development
    Table 57. Astra Zeneca Corporation Information
    Table 58. Astra Zeneca Description and Business Overview
    Table 59. Astra Zeneca Angiotensin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Astra Zeneca Product
    Table 61. Astra Zeneca Recent Development
    Table 62. Jhonson and Johnson Corporation Information
    Table 63. Jhonson and Johnson Description and Business Overview
    Table 64. Jhonson and Johnson Angiotensin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Jhonson and Johnson Product
    Table 66. Jhonson and Johnson Recent Development
    Table 67. Eli Lilly Corporation Information
    Table 68. Eli Lilly Description and Business Overview
    Table 69. Eli Lilly Angiotensin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Eli Lilly Product
    Table 71. Eli Lilly Recent Development
    Table 72. Sanofi Corporation Information
    Table 73. Sanofi Description and Business Overview
    Table 74. Sanofi Angiotensin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Sanofi Product
    Table 76. Sanofi Recent Development
    Table 77. Bristol-Myers Squibb Corporation Information
    Table 78. Bristol-Myers Squibb Description and Business Overview
    Table 79. Bristol-Myers Squibb Angiotensin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Bristol-Myers Squibb Product
    Table 81. Bristol-Myers Squibb Recent Development
    Table 82. Bayer Corporation Information
    Table 83. Bayer Description and Business Overview
    Table 84. Bayer Angiotensin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Bayer Product
    Table 86. Bayer Recent Development
    Table 87. GSK Corporation Information
    Table 88. GSK Description and Business Overview
    Table 89. GSK Angiotensin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. GSK Product
    Table 91. GSK Recent Development
    Table 92. Teva Pharmaceutical Corporation Information
    Table 93. Teva Pharmaceutical Description and Business Overview
    Table 94. Teva Pharmaceutical Angiotensin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 95. Teva Pharmaceutical Product
    Table 96. Teva Pharmaceutical Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Angiotensin Receptor Antagonists Customers List
    Table 100. Angiotensin Receptor Antagonists Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Angiotensin Receptor Antagonists Product Picture
    Figure 2. Global Angiotensin Receptor Antagonists Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Angiotensin Receptor Antagonists Market Size 2017-2028 (US$ Million)
    Figure 4. Global Angiotensin Receptor Antagonists Sales 2017-2028 (K Units)
    Figure 5. United States Angiotensin Receptor Antagonists Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Angiotensin Receptor Antagonists Market Size 2017-2028 (US$ Million)
    Figure 7. United States Angiotensin Receptor Antagonists Sales 2017-2028 (K Units)
    Figure 8. United States Angiotensin Receptor Antagonists Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Angiotensin Receptor Antagonists Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Angiotensin Receptor Antagonists Report Years Considered
    Figure 11. Product Picture of Valsartan
    Figure 12. Product Picture of Telmisartan
    Figure 13. Product Picture of Losartan
    Figure 14. Product Picture of Irbesartan
    Figure 15. Product Picture of Azilsartan
    Figure 16. Product Picture of Olmesartan
    Figure 17. Global Angiotensin Receptor Antagonists Market Share by Type in 2022 & 2028
    Figure 18. Global Angiotensin Receptor Antagonists Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 19. Global Angiotensin Receptor Antagonists Sales Market Share in Value by Type (2017-2028)
    Figure 20. Global Angiotensin Receptor Antagonists Sales by Type (2017-2028) & (K Units)
    Figure 21. Global Angiotensin Receptor Antagonists Sales Market Share in Volume by Type (2017-2028)
    Figure 22. Global Angiotensin Receptor Antagonists Price by Type (2017-2028) & (USD/Unit)
    Figure 23. United States Angiotensin Receptor Antagonists Market Share by Type in 2022 & 2028
    Figure 24. United States Angiotensin Receptor Antagonists Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 25. United States Angiotensin Receptor Antagonists Sales Market Share in Value by Type (2017-2028)
    Figure 26. United States Angiotensin Receptor Antagonists Sales by Type (2017-2028) & (K Units)
    Figure 27. United States Angiotensin Receptor Antagonists Sales Market Share in Volume by Type (2017-2028)
    Figure 28. United States Angiotensin Receptor Antagonists Price by Type (2017-2028) & (USD/Unit)
    Figure 29. Product Picture of Hypertension
    Figure 30. Product Picture of Cardiovascular Diseases
    Figure 31. Product Picture of Kidney Diseases
    Figure 32. Product Picture of Other
    Figure 33. Global Angiotensin Receptor Antagonists Market Share by Application in 2022 & 2028
    Figure 34. Global Angiotensin Receptor Antagonists Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. Global Angiotensin Receptor Antagonists Sales Market Share in Value by Application (2017-2028)
    Figure 36. Global Angiotensin Receptor Antagonists Sales by Application (2017-2028) & (K Units)
    Figure 37. Global Angiotensin Receptor Antagonists Sales Market Share in Volume by Application (2017-2028)
    Figure 38. Global Angiotensin Receptor Antagonists Price by Application (2017-2028) & (USD/Unit)
    Figure 39. United States Angiotensin Receptor Antagonists Market Share by Application in 2022 & 2028
    Figure 40. United States Angiotensin Receptor Antagonists Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 41. United States Angiotensin Receptor Antagonists Sales Market Share in Value by Application (2017-2028)
    Figure 42. United States Angiotensin Receptor Antagonists Sales by Application (2017-2028) & (K Units)
    Figure 43. United States Angiotensin Receptor Antagonists Sales Market Share in Volume by Application (2017-2028)
    Figure 44. United States Angiotensin Receptor Antagonists Price by Application (2017-2028) & (USD/Unit)
    Figure 45. North America Angiotensin Receptor Antagonists Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 46. North America Angiotensin Receptor Antagonists Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. U.S. Angiotensin Receptor Antagonists Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Canada Angiotensin Receptor Antagonists Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Europe Angiotensin Receptor Antagonists Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 50. Europe Angiotensin Receptor Antagonists Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 51. Germany Angiotensin Receptor Antagonists Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. France Angiotensin Receptor Antagonists Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. U.K. Angiotensin Receptor Antagonists Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Italy Angiotensin Receptor Antagonists Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Russia Angiotensin Receptor Antagonists Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Asia-Pacific Angiotensin Receptor Antagonists Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 57. Asia-Pacific Angiotensin Receptor Antagonists Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 58. China Angiotensin Receptor Antagonists Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Japan Angiotensin Receptor Antagonists Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. South Korea Angiotensin Receptor Antagonists Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. India Angiotensin Receptor Antagonists Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Australia Angiotensin Receptor Antagonists Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Taiwan Angiotensin Receptor Antagonists Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Indonesia Angiotensin Receptor Antagonists Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Thailand Angiotensin Receptor Antagonists Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Malaysia Angiotensin Receptor Antagonists Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Philippines Angiotensin Receptor Antagonists Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Latin America Angiotensin Receptor Antagonists Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 69. Latin America Angiotensin Receptor Antagonists Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Mexico Angiotensin Receptor Antagonists Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Brazil Angiotensin Receptor Antagonists Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Argentina Angiotensin Receptor Antagonists Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Middle East & Africa Angiotensin Receptor Antagonists Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 74. Middle East & Africa Angiotensin Receptor Antagonists Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 75. Turkey Angiotensin Receptor Antagonists Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Saudi Arabia Angiotensin Receptor Antagonists Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 77. U.A.E Angiotensin Receptor Antagonists Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 78. Angiotensin Receptor Antagonists Value Chain
    Figure 79. Angiotensin Receptor Antagonists Production Process
    Figure 80. Channels of Distribution
    Figure 81. Distributors Profiles
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed